We’re thrilled to have been invited to speak at the CMT Research Foundation’s #webinar, taking place later today at 19:00ET. Join Dr. Jorge A. Quiroz and Dr. Vera Kiyasova to hear more about our upcoming Phase 2 #ClinicalTrial of NMD670 in patients living with #CMT. Hope to see you there!

Three recruits have joined our management team as we become a Phase 3 ready, clinical-stage organisation. Warm welcome to Peter Kasten as VP Finance, Cecilia Sparr Eskilsson as VP Project Mgmt and Maja B. Nielsen as People & Culture Director. Learn more: nmdpharma.com/news/cmt-estab…

#NMDPharma are thrilled to support Cure SMA’s 2024 Boston Summit of Strength on 20 July. Our SVP, Corporate and Commercial Strategy, Dan Brennan will present on NMD670, an oral therapy for #SMA, currently in Phase 2 development. Join us to hear from experts and the SMA community.

We’re thrilled to welcome Karen Nørby á Rógvu, who joins #NMDPharma as a Senior Clinical Supply Manager. She has a wealth of knowledge on managing supply and coordinating GxP activities, having most recently served as Senior Clinical Drug Supply Manager at Genmab. #NewHire

We’re proud to have published a paper in Neuromuscular Disorders on the role of recovery of acetylcholine release in compromised neuromuscular function, helping us to gain new insights into #neuromuscular function and dysfunction. Read the full paper here: sciencedirect.com/science/articl…

#NMDPharma looks forward to sponsoring Cure SMA’s Norfolk Summit of Strength on 3 August. Our SVP, Corporate and Commercial Strategy, Dan Brennan will present on NMD670, an oral therapy for #SMA. Join us to hear from experts and the SMA community. More: summit-curesma.donordrive.com

Today marks the start of #SMAAwarenessMonth, shining a spotlight on this rare genetic #NeuromuscularDisease. Characterized by degeneration of the motor neurons in the spine, #SMA may cause difficulties in performing everyday activities. curesma.org/sma-awareness-… #RareDisease

Our #research scientists, Jeppe Blichfeldt Winther and Jesper Emil Jakobsgaard, have published a peer-reviewed #JournalClub article in The Journal of Physiology, discussing recent findings on skeletal muscle fatigue. For more: onlinelibrary.wiley.com/share/author/M… #musclephysiology

Follow one of our brilliant research scientists, Michael V. Clausen, as he walks you through a typical day at NMD Pharma, working on groundbreaking research to improve the lives of people suffering from neuromuscular diseases. youtu.be/_5L384XG0Po #DayInTheLife #Research

#NMDPharma were delighted to once again participate in the annual #DHLStafetten at Mindeparken (Memorial Park) in Aarhaus, Denmark. Thank you to everyone who joined us in celebrating our #passion for movement! #NeuromuscularDisease #TeamSpirit

This #SMAAwarenessMonth, our Founder and CEO, @NMDPharma_Thomas teamed up with SMA-Europe for its #WeAreOne campaign, sharing #NMDPharma's passion for movement. Check out his profile below and stay tuned for the documentary launch later this week. #SMA #RareDisease #Biotech

Tomorrow, in honor of #SMAAwarenessMonth, SMA-Europe will launch its #WeAreOne documentary. Together, we can transform #innovation and new ideas into real-life solutions, tailored to the needs of the #SMA community.

Today marks the end of #SMAAwarenessMonth, as well as the launch of SMA-Europe’s #WeAreOne documentary. Be sure to check out the documentary film below and join us in raising awareness of #SMA, not only during August, but year-round.

#NMDPharma’s Dan Brennan and Thomas Groennebaek will attend the @CMTAUSA Patient & Research Summit 6.-8. September in Denver, CO next week. NMD Pharma will present our work in #CMT, and our ongoing Phase 2 #ClinicalTrial. #CMTASummit2024 #CMT #NeuromuscularDisease

Next Monday, from 15:45-16:45CEST, our CEO, Thomas Holm Pedersen, will speak at the first ALBA event, drawing on his experiences as an associate professor & #startup founder to highlight synergies between academia & #Biotech startups in Aarhus. To register: events.au.dk/synergyinscien…

September is #MuscularDystrophyAwareness Month. To mark the occasion, Muscular Dystrophy Association has created the #30DaysOfStrength Campaign, showcasing the many ways we can work to support people living with #NeuromuscularDiseases, such as #MD, #SMA, #MG & #CMT. For more: mda.org/30-ways-30-day…